← Leaderboards
Michael A Levine
Children'S Hosp Of Philadelphia
$9,012,449
Attributed
$10,007,504
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $701K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,007,504 · 7
By mechanism
R01$9,557,945 · 4
T32$449,559 · 1
M01$0 · 2
Top collaborators
- David R Weber3 shared
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- David R Weber$1,568,482
- Struan F A Grant$26,708,768
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypePseudohypoparathyroidismClinical ResearchFamily GeneticsHuman SubjectAllelesLifeSerumCalciumGenesResearch Project GrantsDefectGene MutationInnovationNovel StrategiesUnited States National Institutes Of HealthMissionPathway InteractionsMedicalFundingBaseGenetic PolymorphismGene ExpressionHypoparathyroidism
Grant awards (33)
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1$657,228
R01 · FY2025 · DK · contact PI
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1$701,043
R01 · FY2024 · DK · contact PI
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1$631,840
R01 · FY2023 · DK · contact PI
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1$452,039
R01 · FY2021 · DK · contact PI
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1$497,467
R01 · FY2020 · DK · contact PI
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1$497,467
R01 · FY2019 · DK · contact PI
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1$497,467
R01 · FY2018 · DK · contact PI
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1$497,467
R01 · FY2017 · DK · contact PI
The Role of GCM2 in Parathyroid Gland Homeostasis$548,777
R01 · FY2015 · DK · contact PI
The Role of GCM2 in Parathyroid Gland Homeostasis$548,777
R01 · FY2014 · DK · contact PI
The Role of GCM2 in Parathyroid Gland Homeostasis$529,569
R01 · FY2013 · DK · contact PI
The Role of GCM2 in Parathyroid Gland Homeostasis$565,652
R01 · FY2012 · DK · contact PI
GCMB- Master Regulator of Parathyroid Function$510,071
R01 · FY2010 · DK · contact PI
GCMB- Master Regulator of Parathyroid Function$495,425
R01 · FY2009 · DK · contact PI
CLONING OF THE PSEUDOHYPOPARATHYROIDISM TYPE 1B GENE$267,723
R01 · FY2003 · DK
CLONING OF THE PSEUDOHYPOPARATHYROIDISM TYPE 1B GENE$262,205
R01 · FY2002 · DK
CLONING OF THE PSEUDOHYPOPARATHYROIDISM TYPE 1B GENE$114,579
R01 · FY2002 · DK
Endocrine, Diabetes and Metabolism Training Program$44,548
T32 · FY2002 · DK
ENDOCRINE, DIABETES AND METABOLISM TRAINING PROGRAM$14,632
T32 · FY2002 · DK
CLONING PSEUDOHYPOPARATHYROIDISM TYPE 1B GENE$0
M01 · FY2002 · RR
HORMONE ACTION IN PATIENTS WITH ALTERED G PROTEIN TRANSDUCTION$0
M01 · FY2002 · RR
CLONING OF THE PSEUDOHYPOPARATHYROIDISM TYPE 1B GENE$256,849
R01 · FY2001 · DK
ENDOCRINE, DIABETES AND METABOLISM TRAINING PROGRAM$196,683
T32 · FY2001 · DK
CLONING OF THE PSEUDOHYPOPARATHYROIDISM TYPE 1B GENE$191,176
R01 · FY2001 · DK
CLONING PSEUDOHYPOPARATHYROIDISM TYPE 1B GENE$0
M01 · FY2001 · RR
HORMONE ACTION IN PATIENTS WITH ALTERED G PROTEIN TRANSDUCTION$0
M01 · FY2001 · RR
NUCLEOTIDE REGULATORY UNIT OF ADENYLATE CYCLASE$321,211
R01 · FY2000 · DK
CLONING OF THE PSEUDOHYPOPARATHYROIDISM TYPE 1B GENE$251,649
R01 · FY2000 · DK
ENDOCRINE, DIABETES AND METABOLISM TRAINING PROGRAM$193,696
T32 · FY2000 · DK
CLONING OF THE PSEUDOHYPOPARATHYROIDISM TYPE 1B GENE$186,558
R01 · FY2000 · DK
CLONING OF THE PSEUDOHYPOPARATHYROIDISM TYPE 1B GENE$75,706
R01 · FY2000 · DK
HORMONE ACTION IN PATIENTS WITH ALTERED G PROTEIN TRANSDUCTION$0
M01 · FY2000 · RR
CLONING PSEUDOHYPOPARATHYROIDISM TYPE 1B GENE$0
M01 · FY2000 · RR